NEW YORK, Sept. 2 -- The American Journal of Respiratory Cell and Molecular Biology, a journal from the American Thoracic Society that says it focuses on pulmonary biology, published research articles on the following topics in its September 2022 edition:

Original Research:

* Kasugamycin Is a Novel Chitinase 1 Inhibitor with Strong Antifibrotic Effects on Pulmonary Fibrosis

* Metabolic and Epigenetic Regulation of SMAD7 by STC1 Ameliorates Lung Fibrosis